Navigation Links
Pamela G. Bailey and Edward R. Casas, M.D. Appointed to MedCath's Board of Directors
Date:4/7/2008

CHARLOTTE, N.C., April 7, 2008 /PRNewswire-FirstCall/ -- MedCath Corporation (Nasdaq: MDTH) announced today that Pamela G. Bailey and Edward R. Casas have been appointed to its Board of Directors.

Ms. Bailey, currently President and Chief Executive Officer for Personal Care Products Council, brings significant leadership and health care policy experience to the MedCath Board of Directors. She has served as President and Chief Executive Officer of Advanced Medical Technology Association, a Washington, D.C.-based trade association and the largest medical technology association in the world. In addition, she was founding Chief Executive Officer and President of Healthcare Leadership Council, an association of over 50 health care industry chief executives, and served as President of National Committee for Quality Health Care, a leader and advocate for market-based health care reforms in the national health care debates of the 1990s. She also served in the White House for three United States Presidents: Ronald Reagan, Gerald Ford and Richard Nixon.

Dr. Casas, currently Managing Director and Co-Head of Navigant Capital Advisors, brings considerable financial and capital markets experience and knowledge to the MedCath Board of Directors. He currently oversees the Investment Banking, Restructuring, Valuation and Transaction Services practice areas that provide advisory support for Navigant clients. He served as a member of Navigant Consulting, Inc.'s (NYSE: NCI) Senior Management Committee. Previously, he was a founding Member and Senior Managing Director of Casas, Benjamin & While, LLC, a leading boutique mergers, acquisitions, private equity and financial restructuring firm. He also served as President and Chief Executive Officer of PrimeCare International, Inc. and as Vice President, Mergers and Acquisitions, for Caremark International, Inc. He served in the United States Navy, U.S. Marine Corps. as a Flight Surgeon.

"We are extremely pleased to add the experience and leadership of Ms. Bailey and Dr. Casas to our Board of Directors," said Board Chairman John Casey. "They each possess considerable qualities and attributes that make them ideal directors for MedCath. I welcome them to the Board."

The new board members will begin serving immediately. Also, Edward A. Gilhuly has retired from the board. Mr. Gilhuly has been a director since August 1998. In January 2006, Mr. Gilhuly became a member of Sageview Capital LLC. Prior to that, he was an executive of Kohlberg Kravis Roberts and Co., L.P. and a general partner from January 1995, before becoming a member of the limited liability company which serves as the general partner of KKR in January 1996. Mr. Gilhuly was managing director of Kohlberg Kravis Roberts & Co. Ltd., the London-based affiliate of KKR, prior to forming Sageview.

"Mr. Gilhuly has helped MedCath grow considerably during his nearly 10 years on the Board, and we are incredibly grateful for the insight and leadership he provided," Casey said.

MedCath Corporation, headquartered in Charlotte, N.C., is a healthcare provider focused on high acuity services with the diagnosis and treatment of cardiovascular disease being a primary service offering. MedCath owns interests in and operates ten hospitals with a total of 663 licensed beds, located in Arizona, Arkansas, California, Louisiana, New Mexico, Ohio, South Dakota, and Texas. In addition, MedCath and its subsidiary MedCath Partners provide services in diagnostic and therapeutic facilities in various states.


'/>"/>
SOURCE MedCath Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. The G&P Foundation Celebrates 10 Years of Funding Life Saving Research at The 2007 Angel Ball Honoring Glenda Bailey, Debra L. Lee, Dr. Stephen D. Nimer and the Late H.H. Sheik Zayed Bin Sultan Al Nahyan
2. Statement by John Bailey, EVP for Science Cosmetic, Toiletry, and Fragrance Association on Campaign for Safe Cosmetics Report on Lead in Lipstick
3. Edwards Lifesciences Chairman and CEO Adopts New 10b5-1 Stock Trading Plan to Replace Recently Expired Plan
4. Edwards Lifesciences to Present at the Citi 5th Annual Small and Mid-Cap Conference
5. Edwards Lifesciences to Present at the Cowen and Company Annual Healthcare Conference
6. Statement by Dr. Edward Jones, Chairman of Kidney Care Partners in Response to CMS Payment Bundling Report
7. Edwards Lifesciences Initiates Patent Infringement Litigation Against CoreValve in the U.S.
8. Edwards Lifesciences Reports Strong Fourth Quarter Sales
9. ChemoCentryx Appoints Edward E. Penhoet, Ph.D., to Board of Directors
10. Edwards Lifesciences Completes Sale of LifeStent Product Line to Bard
11. Edward Hospital Statement Regarding Indictment of P. Nicholas Hurtgen
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... 2017 , ... A recent report from the Wisconsin Institute ... 2015-16 school year across Wisconsin’s public schools, charter schools, and private schools participating ... student test score performance, the report’s limited analyses fail to provide answers as ...
(Date:4/25/2017)... Las Vegas, NV (PRWEB) , ... April 25, ... ... teeth can now choose a modern procedure that achieves results in a fraction ... orthodontist in Las Vegas, NV, with Significance Dental Specialists, now offers this ...
(Date:4/25/2017)... Atlanta, GA (PRWEB) , ... April 25, 2017 , ... ... to their neck and back pain with a reputable physician in their area, announces ... The CRM protects patient information for patients who are looking for reputable physicians to ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... predictive analytics to its patient care management module. Using this new feature, sleep ... patient has been initiated on continuous positive airway pressure (CPAP), oral, or other ...
(Date:4/25/2017)... , ... April 25, 2017 , ... ... large animal healthcare products, is introducing Flexadin UCII, part of the EQUISTRO line, ... development and joint health in horses at the immunologic level. , The scientifically-developed ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... 2017  SARES•REGIS Group leased the first of ... Conejo Spectrum Business Park in Thousand ... Inc. , a biopharmaceutical company developing meaningful therapies ... have been underserved by scientific innovation, with an ... autoimmune and infectious disease. Before commencement ...
(Date:4/18/2017)... , April 18, 2017 Cogentix Medical, ... on providing the Urology, Uro/Gyn and Gynecology markets with ... the first quarter ended March 31, 2017 after the ... The Company will host a conference call and ... on Tuesday, May 2, 2017 at 4:30 p.m. Eastern ...
(Date:4/18/2017)... Research and Markets has announced the addition of the ... ... to grow at a CAGR of 6.35% during the period 2017-2021. ... been prepared based on an in-depth market analysis with inputs from ... prospects over the coming years. The report also includes a discussion ...
Breaking Medicine Technology: